
|Articles|October 15, 2011
Tissue treats graft failure
Grafting a thicker amniotic membrane onto the ocular surface may be a promising solution for patients who experience graft failure or require ocular surface reconstruction after penetrating keratoplasty.
Advertisement
A product from IOP Ophthalmics (Ambio5) is a dehydrated amniotic membrane tissue that seems to improve the outcomes following amniotic membrane transplantation.
He has used this product successfully in more than 200 cases and described a particularly difficult case in which the patient had undergone a previous graft rejection and had a complicated medical history.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
2
PRIMA retinal implant restores vision in patients with advanced GA
3
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5














































